해조류 다당류와 Chitosan, Chitin의 항바이러스 효과 = Antiviral Activity of Chitosan, Chitin and Polysaccharides Derived From Seaweed

다국어 초록 (Multilingual Abstract)

The corona virus is terrifying and fearing people all over the world. About 8 million people have been identified worldwide and about 400,000 have died, threatening human health since the Spanish flu in the early 20th century. To overcome COVID-19, no specific antiviral treatment or vaccine has been developed that can be used to control or suppress infection. More than 300 drugs are being developed for prophylactic and therapeutic purposes because the development of therapeutic agents is required before vaccine development, and many drugs are in clinical trials. In addition, vaccine development is actively underway to complete the end of COVID-19. In addition, major countries around the world, including Korea, are participating in vaccine development. On the other hand, the study of natural antiviral substances to improve safety by following the treatment of COVID-19 before the vaccine is developed is also of interest. In natural products with antiviral activity, propolis, Manuka honey, boswellia gem, myrrh and xylitol, and many essential oils and polyphenols are attracting attention. Along with this, marine polysaccharides such as carrageenan, alginic acid, fucan and chitosan are also of great interest. Chitosan, which is the central theme of this society, has been shown to be a hope for the complete overcoming of COVID-19 by exhibiting high binding and high antiviral effects with viruses due to its molecular properties and its characteristic transformation. Corona virus vaccines have been developed in the future and we hope that they will be used as a wide range of antiviral substances until we return to a safe routine.

참고문헌 (Reference)

1 박수은, "코로나바이러스감염증-19의 바이러스(SARS-CoV-2) 특징, 전파 및 임상 양상" 대한소아감염학회 27 (27): 1-10, 2020

2 "코로나바이러스감염증-19(COVID-19) 질병관리본부 환자 현황"

3 Mercer, J., "Virus entry by endocytosis" 79 : 803-833, 2010

4 Harden, E. A., "Virucidal activity of polysaccharide extracts from four algal species against herpes simplex virus" 83 : 282-289, 2009

5 Copeland, R., "Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1" 47 : 5774-5783, 2008

6 Kim, S. K., "Therapeutic prospectives of chitin, chitosan and their derivatives" 11 : 1-10, 2006

7 Carter, D. A., "Therapeutic Manuka Honey: No Longer So Alternative" 569 : 1-11, 2016

8 Geng, M. Y., "The potential molecular targets of marine sulfated polymannuroguluronate interfering with HIV-1 entry Interaction between SPMG and HIV-1 gp120 and CD4 molecule" 59 : 127-135, 2003

9 Wang, W., "The application of polymannuronic acid propyl sulfate in the preparation of drugs against influenza A (H1N1) virus"

10 Biancatelli, R. M. L. C., "The antiviral properties of vitamin C" 18 : 99-101, 2020

11 Talarico, L. B., "The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell" 66 : 103-110, 2005

12 Chirkov, S. N., "The antiviral activity of chitosan (review)" 38 : 1-8, 2002

13 Wang, W., "The Antiviral Activities and Mechanisms of Marine Polysaccharides: An Overview" 10 : 2795-2816, 2012

14 McCandless, E. L., "Sulphated polysaccharidesin red and brown algae" 112 : 201-212, 1979

15 Damonte, E. B., "Sulfated seaweed polysaccharides as antiviral agents" 11 : 2399-2419, 2004

16 McCandless, E. L., "Sulfated polysaccharidesin red and brown algae" 30 : 41-53, 1979

17 Baba, M., "Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus" 32 : 1742-1745, 1988

18 Neyts, J., "Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate" 189 : 48-58, 1992

19 Miao, B. C., "Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome(AIDS)drug candidate, targeting CD4 in lymphocytes" 68 : 641-649, 2004

20 Jiang, B. F., "Study on ―911? anti-HBV effect in HepG2.2.15 cells culture" 30 : 517-518, 2003

21 Xin, X. L., "Study on the mechanism of inhibitory action of 911 on replication of HIV-1 in vitro" 19 : 15-18, 2000

22 Xin, X. L., "Studies of the anti-AIDS effects of marine polysaccharide drug 911 and its related mechanisms of action" 6 : 4-8, 2000

23 Hidari, K. I. P. J., "Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga" 376 : 91-95, 2008

24 Matsuhiro, B., "Structural analysis and antiviral activity of a sulfated galactan from the red seaweed Schizymenia binderi (Gigartinales, Rhodophyta)" 340 : 2392-2402, 2005

25 Nishimura, S. I., "Regioselective syntheses of sulfated polysaccharides: Specificanti-HIV-1 activity of novel chitin sulfates" 306 : 427-433, 1998

26 Carlucci, M. J., "Protective effect of a natural carrageenan on genital herpes simplex virus infection in mice" 64 : 137-141, 2004

27 Jeon, Y. J., "Production of chitooligosaccharidesusing ultrafiltration membrane reactor and their antibacterial activity" 41 : 133-141, 2000

28 Chiu, Y. H., "Prevention of human enterovirus 71 infection by kappa carrageenan" 95 : 128-134, 2012

29 Yamada, T., "Preparation of O-acylated low-molecular-weight carrageenans with potent anti-HIV activity and low anticoagulant effect" 41 : 115-120, 2000

30 Tang, F., "Preparation and potential in vivo anti-influenza virus activity of low molecular-weight κ-carrageenans and their derivatives" 127 : 2110-2115, 2013

31 Wang, W., "Preparation and anti-influenza A virus activity of κ-carrageenan oligosaccharide and its sulphated derivatives" 133 : 880-888, 2012

32 Yamada, T., "Preparation and anti-HIV activity of low-molecular-weight carrageenans and their sulfated derivatives" 32 : 51-55, 1997

33 Vo, T. -S., "Potential anti-HIV agents from marine resources: An overview" 8 : 2871-2892, 2010

34 González, M. E., "Polysaccharidesas antiviral agents: Antiviral activity of carrageenan" 31 : 1388-1393, 1987

35 Muto, S., "Polysaccharides from marine algae and antiviral drugs containing the same as active ingredients"

36 Stortz, C. A., "Novel findings in carrageenans,agaroids and hybrids red seaweed galactans" 4 : 121-134, 2000

37 World Health Organization, "Novel coronavirus (2019-nCoV), situation report-1, 21" World Health Organization

38 Guan, H. S, "New drug-polymeric mannuronic acids sulfate"

39 Sosa, M. A., "N-carboxymethyl chitosan-N, O-sulfate as an anti-HIV-1 agent" 174 : 489-496, 1991

40 Liu, H. Y., "Multiple and multivalent interactions of novel anti-AIDS drug candidates, sulfated polymannuronate(SPMG)-derived oligosaccharides, with gp120 and their anti-HIV activities" 15 : 501-510, 2005

41 Mazumder, S., "Isolation, chemical investigation and antiviral activity of polysaccharides from Gracilaria corticata(Gracilariaceae, Rhodophyta)" 31 : 87-95, 2002

42 Akamatsu, E., "Isolation of an anti-influenza virus substance, MC26 from a marine brown alga, Sargassum piluliferum and its antiviral activity against influenza virus" 29-34, 2003

43 Leibbrandt, A., "Iota-carrageenan is a potent inhibitor of influenza A virus infection" 5 : e14320-, 2010

44 Grassauer, A., "Iota-Carrageenan is a potent inhibitor of rhinovirus infection" 5 : 107-, 2008

45 Turner, E. V., "Interferon induction by the immunomodulating polyanion Lambda carrageenan" 25 : 467-469, 1979

46 Talarico, L. B., "Interference in dengue virus adsorption and uncoating by carrageenans" 363 : 473-485, 2007

47 Carlucci, M. J., "Inhibitory action of natural carrageenans on herpes simplex virus infection of mouse astrocytes" 45 : 429-436, 1999

48 Ramos-Kuri, M., "Inhibition of three alpha herpes viruses(herpes simplex 1 and 2 and pseudo rabies virus)by heparin, heparan and other sulfated polyelectrolytes" 27 : 43-48, 1996

49 Queiroz, K. C. S., "Inhibition of reverse transcriptase activity of HIV by polysaccharides of brown algae" 62 : 303-307, 2008

50 Pospieszny, H., "Induction of antiviral resistance in plants by chitosan" 79 : 63-68, 1991

51 Zhou, G., "In vivo antitumor and immunomodulation activities of different molecular weight lambda-carrageenans from Chondrus ocellatus" 50 : 47-53, 2004

52 Wang, W., "In vitro inhibitory effect of carrageenan oligosaccharide on influenza A H1N1 virus" 92 : 237-246, 2011

53 Kim, J. K., "In vitro and in vivo immunomodulatory activity of sulfated polysaccharides from Enteromorpha prolifera" 49 : 1051-1058, 2011

54 Yuan, H. M., "Immunomodulation and antitumor activity of κ-carrageenan oligosaccharides" 243 : 228-234, 2006

55 Li, S. Chen, C., "Identification of natural compounds with antiviral activities against SARS-associated coronavirus" 67 : 18-23, 2005

56 Carlucci, M. J., "Herpes simplex virus type 1variants arising after selection with an antiviral carageenan: Lack of correlation between drug susceptibility and syn phenotype" 68 : 92-98, 2002

57 Nelson, R. M., "Heparin oligosaccharidesbind L-and P-selectin and inhibit acute inflammation" 82 : 3253-3258, 1993

58 Delattre, C., "Galactans: an overview of their most important sourcing and applications as natural polysaccharides" 54 : 1075-1092, 2011

59 Rodr´ıguez, M. C., "Galactans from cystocarpic plants of the red seaweed Callophyllis variegata (Kallymeniaceae, Gigartinales)" 340 : 2742-2751, 2005

60 Douglas, M. S., "Endothelial production of MCP-1: Modulation by heparin and consequences for mononuclear cell activation" 92 : 512-518, 1997

61 Dou, J. L., "Effects of chitooligosaccharides on rabbit neutrophils in vitro" 69 : 209-213, 2007

62 Davis, R., "Effectiveness of chitosan on the inactivation of enteric viral surrogates" 32 : 57-62, 2012

63 Kulikov, S. N., "Effect of the molecular weight of chitosan on its antiviral activity in plants" 42 : 224-228, 2006

64 Su, X. W., "Effect of chitosan on the infectivity of murine norovirus, feline calicivirus, and bacteriophage MS2" 72 : 2623-2628, 2009

65 Pospieszny, H., "Effect of chitosan on the hypersensitive reaction of bean to alfalfa mosaic virus" 62 : 29-31, 1989

66 Talarico, L. B., "Differential inhibition of dengue virus infection in mammalian and mosquito cells by iota-carrageenan" 92 : 1332-1342, 2011

67 Madeleine, L. M., "Dextran sulfate inhibits the fusion of influenza virus with model membranes, and suppresses influenza virus replication in vivo" 14 : 39-50, 1990

68 Lahaye, M., "Developments on gelling algal galactans, their structure and physico-chemistry" 13 : 173-184, 2001

69 Estevez, J. M., "DL-Galactan hybrids and agarans from gametophytes of the red seaweed Gymnogongrus torulosus" 331 : 27-41, 2001

70 Peng, X. M., "Current Developments of Coumarin Compounds in Medicinal Chemistry" 19 : 3884-3930, 2013

71 Wrapp, D., "Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation" 13 (13): 1260-1263, 2020

72 Mishra, S., "Coumarin: An emerging antiviral agent Heliyon" 6 : e03217-, 2020

73 Jeon, Y. J., "Continuous production of chitooligosaccharides using a dual reactor system" 35 : 623-632, 2000

74 Davydova, V. N., "Chitosan antiviral activity: Dependence on structure and depolymerization method" 47 : 113-118, 2011

75 Jiao, G., "Chemical structures and bioactivities of sulphated polysaccharides from marine algae" 9 : 196-223, 2011

76 Buck, C. B., "Carrageenan is a potent inhibitor of papillomavirus infection" 2 : e69-, 2006

77 전환주, "COVID-19 대응을 위한 국내외 치료제 및 백산개발 현황과 과제" 2-32, 2020

78 Kim, H. M., "COVID-19 과학 리포트 : 코로나바이러스-19의 구조적 특징과 침투경로를 차단하는 치료전략"

79 Rashan, L., "Boswellia Gum Resin and Essential Oils: Potential Health Benefits - An Evidence Based Review" 9 : 53-71, 2019

80 Ji, J., "Bio-function summary of marine oligosaccharides" 3 : 74-86, 2011

81 Okazaki, K., "BHV-1 adsorption is mediated by the interaction of glycoprotein gIII with heparinlike moiety on the cell surface" 181 : 666-670, 1991

82 Girond, S., "Antiviral activity of carrageenan on hepatitis A virus replication in cell culture" 142 : 261-270, 1991

83 Ahmadi, A., "Antiviral Potential of Algae Polysaccharides Isolated from Marine Sources: A Review" 1-10, 2015

84 Ahmadi, A., "Antiviral Potential of Algae Polysaccharides Isolated from Marine Sources: A Review" 2015 : 825203-, 2015

85 Ho, H. Y., "Antiviral Effect of Epigallocatechin Gallate on Enterovirus 71" 57 : 6140-6147, 2009

86 Schnitzler, P., "Antiviral Activity and Mode of Action of Propolis Extracts and Selected Compounds" 24 : 20-28, 2010

87 Min S. K., "Antiviral Activity Screening of Aqueous Extracts from Indigenous Plants" 19 : 9-19, 2009

88 Yu, L., "Antitumor effect of butanoylated heparin with low anticoagulantactivity on lung cancer growth in mice and rats" 10 : 229-241, 2010

89 Carlucci, M. J., "Antiherpetic and anticoagulant properties of carrageenans from the red seaweed Gigartina skottsbergii and their cyclized derivatives: Correlation between structure and biological activity" 20 : 97-105, 1997

90 Carlucci, M. J., "Antiherpetic activity and mode of action of natural carrageenans of diverse structural types" 43 : 93-102, 1999

91 Carlucci, M. J, "Antiherpetic activity and mode of action of natural carrageenans of diverse structural types" 43 : 93-102, 1999

92 Brochot, A., "Antibacterial, antifungal, and antiviral effects of three essential oil blends" 6 : 459-465, 2017

93 Artan, M., "Anti-HIV-1 activity of low molecular weight sulfated chitooligosaccharides" 345 : 656-662, 2010

94 Karagozlu, M. Z., "Anti-HIV activities of novel synthetic peptide conjugated chitosan oligomers" 66 : 260-266, 2014

95 Talarico, L. B., "An algal-derived DL-galactan hybrid is an efficient preventing agent for in vitro dengue virus infection" 73 : 1464-1468, 2007

96 Xu, M. L., "Ameliorating Effect of Dietary Xylitol on Human Respiratory Syncytial Virus(hRSV)Infection" 39 : 540-546, 2016

97 Witvrouw, M., "Activity of a sulfated polysaccharide extracted fromthe red seaweed Aghardhiella tenera against human immunodeficiency virus and other enveloped viruses" 5 : 297-303, 1994

98 Kari, B., "A human cytomegalovirus glycoproteincomplex designated gC-II is a major heparin-binding component of the envelope" 66 : 1761-1764, 1992